GSK

@GSK

We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: gsk.to/socialmedia

London, UK

GSK
@GSK
9h
#News for #investors and #media: Today, our licensor Hansoh Pharma presented positive data at #WCLC26 from a pivotal trial of an investigational antibody-drug conjugate in our pipeline. Learn more: gsk.to/4xRUa7t
00:00
1
GSK
@GSK
Sep 10
#News for #Investors and #Media: Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved a new prefilled syringe presentation of one of our vaccines. Learn more: gsk.to/4xSAW1Q
00:00
1
GSK
@GSK
Sep 9
The data we’ve shared at #ERSCongress underscores how much more we can achieve for respiratory patients when science and partnership come together. Building on our proven track record of innovation, we’re accelerating our R&D programmes in COPD to target multiple inflammatory
00:00
GSK
@GSK
Sep 4
#Media #Investors Climate change is one of the greatest threats to human health, and its impact on patients with respiratory health conditions should not be underestimated. Through advances in sustainable respiratory care, we’re making progress towards our environmental goals.
00:00
6
GSK
@GSK
Sep 1
#News for #Investors and #Media: Today we announced Phase II data for a seasonal flu vaccine candidate at #OPTIONSXIII. Learn more: gsk.to/3Sqbt0e
00:00
2